Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines
Fiche du document
2017
- handle: 10670/1.ruae3w
- 1413-8123
Ce document est lié à :
http://www.redalyc.org/revista.oa
Ciência & Saúde Coletiva
Mots-clés
Salud Government programs Pharmaceutical trade Antihypertensive agents Pharmaceutical services Interrupted time series analysisCiter ce document
Rondineli Mendes da Silva et al., « Farmácia Popular Program: pharmaceutical market analysis of antihypertensive acting on the renin-angiotensin system medicines », Ciência & Saúde Coletiva, ID : 10670/1.ruae3w
Métriques
Partage / Export
Résumé
"This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil . The retro - spective longitudinal analyses focus on therapeu - tic class of agents acting on the renin-angiotensin system . Data obtained from QuintilesIMS (for - merly IMS Health) included private retail phar - macy sales volume (pharmaceutical units) and sales values from 2002 to 2013 . Analyses evaluat - ed changes in market share following key FP poli - cy changes . The therapeutic class was selected due to its relevance to hypertension treatment . Market share was analysed by therapeutic sub-classes and by individual company . Losartan as a single prod - uct accounted for the highest market share among angiotensin II antagonists . National companies had higher sales volume during the study period, while multinational companies had higher sales value . Changes in pharmaceutical market share coincided with the inclusion of specific products in the list of medicines covered by FP and with in - creases in or exemption from patient copayment."